Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,762
datasets available to search
ShareScore release 0.9.0
Dataset results
3,762 results for “Combination treatment”
Interventional Study to Evaluate the Combination of Palbociclib + Sunitinib as a Treatment for Advanced Solid Tumors
ClinicalTrials.gov study NCT06940349. IPD Sharing: NO. Countries: 1. Publications: 0.
The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia
ClinicalTrials.gov study NCT07362355. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Combination Treatment for Moderate to Severe Acne
ClinicalTrials.gov study NCT01206348. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and Dyslipidemia
ClinicalTrials.gov study NCT03338426. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and Safety
ClinicalTrials.gov study NCT06531278. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung Cancer
ClinicalTrials.gov study NCT05913089. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma
ClinicalTrials.gov study NCT05204524. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Stromal Vascular Fraction and Autologous Activated Platelet-Rich Plasma Combination in Treating Treatment of Type 2 Diabetes
ClinicalTrials.gov study NCT05925829. IPD Sharing: NO. Countries: 1. Publications: 0.
Combination Treatment With BTL-899 and HPM-6000UF Devices II
ClinicalTrials.gov study NCT05713864. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unresectable MSS-Type, RAS-Mutated Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT06218810. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Sintilimab or Placebo in Combination With Chemotherapy as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer With Wild-type EGFR After Failure With Plat
ClinicalTrials.gov study NCT03863483. IPD Sharing: NO. Countries: 1. Publications: 0.
PRP Combined With Botulinum Toxin Type A Injection for the Treatment of Androgenetic Alopecia: A Study
ClinicalTrials.gov study NCT07335367. IPD Sharing: NO. Countries: 0. Publications: 0.
A Multi-center, Two-arm, Phase 2 Clinical Study on the Perioperative Treatment of HER2-positive Resectable Esophagogastric Junctional Adenocarcinoma With Nabulimab Combined With FLOT and Trastuzumab V
ClinicalTrials.gov study NCT06681298. IPD Sharing: YES. Countries: 1. Publications: 0.
OT-101 in Combination With Atezolizumab for the Treatment of Metastatic or Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT05935774. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate the Safety and Preliminary Signs of Efficacy of [177Lu]Lu-OncoFAP-23 Alone or in Combination With L19-IL2 as a Treatment of Metastatic FAP-positive Solid Tumors
ClinicalTrials.gov study NCT06640413. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in Combination With Bortezomib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL)
ClinicalTrials.gov study NCT00407303. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia Areata
ClinicalTrials.gov study NCT06327581. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Combination of Adebrelimab, Apatinib, and Lrinotecan Liposome for Second-line Treatment of Advanced Gastric Cancer
ClinicalTrials.gov study NCT06592287. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Anrotinib Hydrochloride Combined With Adriamycin for Neoadjuvant Treatment of High-grade Soft Tissue Sarcoma
ClinicalTrials.gov study NCT05747521. IPD Sharing: NO. Countries: 1. Publications: 0.
Induction Tislelizumab Combined With Chemotherapy Followed by Definitive Chemoradiotherapy in the Treatment of Locally Unresectable Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT05515315. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.